PharmaDispatch, a publication owned and operated by Daily Dispatch Pty Ltd, is dedicated to breaking news and commentary on the Australian pharmaceutical and life sciences sector.
The publisher of PharmaDispatch is Paul Cross, a former ministerial adviser to two Australian Health Ministers and senior pharmaceutical industry executive in Australia and the US.
It is an independent news service providing coverage, opinion and analysis.
The service, which was launched in 2012, aims to provide a new perspective on policy, funding, political and sector specific matters.
PharmaDispatch is published by Daily Dispatch Pty Ltd (ABN: 551 599 92 999), which also publishes BiotechDispatch.
Another senior official leaves pharmaceutical benefitsJuly 21, 2017 -
TPP11 discussions continueJuly 21, 2017 - Latest News
Second year of Astellas C3 PrizeJuly 21, 2017 - Latest News
AFT secures new deal for MaxigesicJuly 21, 2017 - Latest News
New HCV therapy for PBS in AugustJuly 20, 2017 - Latest News
First generics of popular pain therapyJuly 20, 2017 - Latest News
Quilty: Whole of sector challengeJuly 20, 2017 - Latest News